Literature DB >> 21115947

The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia.

David Fernández-López1, Jesús M Pradillo, Isaac García-Yébenes, José A Martínez-Orgado, María A Moro, Ignacio Lizasoain.   

Abstract

BACKGROUND AND
PURPOSE: The endocannabinoid system has been involved in the modulation of neural stem cells proliferation, survival and differentiation as well as in the generation of new oligodendrocyte progenitors in the postnatal brain. The present work aims to test the effect of the synthetic Type 1 and Type 2 cannabinoid receptor agonist WIN55212-2 on these processes in the context of neonatal rat brain hypoxia-ischemia (HI).
METHODS: P7 Wistar rats were subjected to HI and treated either with WIN55212-2 (1 mg/kg) or vehicle twice daily for 7 days after HI and euthanized at 1, 2, 7, 14, or 28 days to explore white matter injury progression and the neurogenic response in the subventricular zone after HI.
RESULTS: Our findings reveal that WIN55212-2 promotes remyelination of the injured external capsule, increasing the number of NG2+ early oligodendrocyte progenitors 7 days after HI in this area and the number of APC+ mature oligodendrocytes in the injured striatum 14 and 28 days after HI. WIN55212-2 also increases cell proliferation and protein expression of the neuroblast marker doublecortin in the subventricular zone 7 days after neonatal HI as well as the number of newly generated neuroblasts (5-bromodeoxyuridine+/doublecortin+ cells) in the ipsilateral striatum 14 days after HI.
CONCLUSIONS: Our results suggest that the activation of the endocannabinoid system promotes white and gray matter recovery after neonatal HI injury.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21115947     DOI: 10.1161/STROKEAHA.110.599357

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  20 in total

1.  Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke.

Authors:  D Fernández-López; J Faustino; N Derugin; M Wendland; I Lizasoain; M A Moro; Z S Vexler
Journal:  Neuroscience       Date:  2012-01-12       Impact factor: 3.590

2.  Inhibition of CD147 improves oligodendrogenesis and promotes white matter integrity and functional recovery in mice after ischemic stroke.

Authors:  Shan Liu; Rong Jin; Adam Y Xiao; Wei Zhong; Guohong Li
Journal:  Brain Behav Immun       Date:  2019-07-26       Impact factor: 7.217

3.  The Cannabinoid Receptor Agonist WIN55,212-2 Ameliorates Hippocampal Neuronal Damage After Chronic Cerebral Hypoperfusion Possibly Through Inhibiting Oxidative Stress and ASK1-p38 Signaling.

Authors:  Da-Peng Wang; Qiao-Li Lv; Qi Lin; Kai Kang; Kai-Yan Jin; Jian Hai
Journal:  Neurotox Res       Date:  2019-12-05       Impact factor: 3.911

4.  The cannabinoid WIN 55212-2 mitigates apoptosis and mitochondrial dysfunction after hypoxia ischemia.

Authors:  D Alonso-Alconada; A Alvarez; F J Alvarez; J A Martínez-Orgado; E Hilario
Journal:  Neurochem Res       Date:  2011-09-11       Impact factor: 3.996

Review 5.  Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Enrique Hilario
Journal:  Neurosci Bull       Date:  2011-08       Impact factor: 5.203

6.  Promoting Oligodendrocyte Differentiation from Human Induced Pluripotent Stem Cells by Activating Endocannabinoid Signaling for Treating Spinal Cord Injury.

Authors:  Hong Gao; Ying Guo; Sangita Biswas; Jing Li; Haojie Zhang; Zhaolin Chen; Wenbin Deng
Journal:  Stem Cell Rev Rep       Date:  2022-06-20       Impact factor: 5.739

Review 7.  Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.

Authors:  Javier Fernández-Ruiz; María A Moro; José Martínez-Orgado
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

Review 8.  Perinatal hypoxic-ischemic damage: review of the current treatment possibilities.

Authors:  A Frajewicki; Z Laštůvka; V Borbélyová; S Khan; K Jandová; K Janišová; J Otáhal; J Mysliveček; V Riljak
Journal:  Physiol Res       Date:  2020-12-31       Impact factor: 1.881

Review 9.  Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.

Authors:  Mauro Maccarrone; Manuel Guzmán; Ken Mackie; Patrick Doherty; Tibor Harkany
Journal:  Nat Rev Neurosci       Date:  2014-12       Impact factor: 38.755

10.  Cannabinoids: well-suited candidates for the treatment of perinatal brain injury.

Authors:  David Fernández-López; Ignacio Lizasoain; Maria Angeles Moro; José Martínez-Orgado
Journal:  Brain Sci       Date:  2013-07-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.